Close

Sarepta Therapeutics (SRPT): Cash Enough To Reach Profitability - Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BSX
8. PI
9. NOW
10. CNMD


Go back to Sarepta Therapeutics (SRPT): Cash Enough To Reach Profitability - Oppenheimer
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 127.25 +3.00 (2.41%)
Previous Close $124.25    52 Week High $63.73 
Open $123.00    52 Week Low $8.00 
Day High $130.61    P/E N/A 
Day Low $121.80    EPS $-5.69 
Volume 913,890